The role of nitric oxide in reflux nephropathy

Pediatric Surgery International

Volumn 18, Issue 7, 2002, Pages 630-634

  Chertin, Boris ^a   Rolle, Udo ^a   Farkas, Amicur ^b   Puri, Prem ^a  

^a UNIVERSITY COLLEGE DUBLIN   (Ireland)

^b HEBREW UNIVERSITY OF JERUSALEM   (Israel)

Author keywords

Nitric oxide; Reflux nephropathy; Renal fibrosis; Vesicoureteral reflux

Indexed keywords

NITRIC OXIDE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE; TRANSFORMING GROWTH FACTOR BETA1;

ADOLESCENT; CHILD; CLINICAL ARTICLE; CONFERENCE PAPER; CONFOCAL MICROSCOPY; CONTROLLED STUDY; EXTRACELLULAR MATRIX; GLOMERULUS CAPILLARY; HISTOCHEMISTRY; HUMAN; HUMAN TISSUE; IMMUNOREACTIVITY; INFANT; KIDNEY CELL; KIDNEY FIBROSIS; LASER MICROSCOPY; NICK END LABELING; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN TRANSPORT; REFLUX NEPHROPATHY; TRANSPORT KINETICS;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; HUMANS; INFANT; KIDNEY; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE I; NITRIC OXIDE SYNTHASE TYPE II; NITRIC OXIDE SYNTHASE TYPE III; VESICO-URETERAL REFLUX;

EID: 0036820920     PISSN: 01790358     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00383-002-0858-4     Document Type: Conference Paper

References (21)

1. Smellie JM, Barratt TM, Chantler C, et al (2001) Medical versus surgical treatment in children with severe bilateral vesicoureteric reflux and bilateral nephropathy: a randomised trial. Lancet 357: 1329-1333
2. International Reflux Study Committee (1981) Medical versus surgical treatment of primary vesicoureteric reflux. Pediatrics 67: 392-400
3. Goonasekera CDA, Dilon MJ (1999) Hypertension in reflux nephropathy. BIJ Int 83: 1-12
4. Zuccheli P, Gaggi R (1991) Reflux nephropathy in adults. Nephron 57: 2-9
5. Smellie JM, Normand C (1979) Reflux nephropathy in childhood. In: Hodson J, Kincaid-Smith P (eds) Reflux nephropathy. Masson, New York, pp 14-20
6. Matsuoka H, Oshima K, Sakamoto K (1994) Renal pathology in patients with reflux nephropathy. Eur Urol 26: 153-159
7. Klahr S (1991) New insights into the consequences and mechanisms of renal impairment in obstructive nephropathy. Am J Kidney Dis 18: 689-673
8. Huang A, Palmer LS, Hom D, et al (2000) The role of nitric oxide in obstructive nephropathy. J Urol 163: 1276-1281
9. Moncada S, Palmer RMJ, Higgs EA (1991) Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol Rev 43: 109-142
10. Monsada S (1999) Nitric oxide: discovery and impact on clinical medicine. J R Soc Med 92: 164-169
11. Narita I, Border WA, Ketteler M, et al (1995) Nitric oxide mediates immunologic injury to kidney mesangium in experimental glomerulonephritis. Lab Invest 72: 17-24
12. Klahr S, Morrissey J (1995) Renal disease: the two faces of nitric oxide. Lab Invest 72: 1-3
13. Harrison DG (1997) Cellular and molecular mechanisms of endothelial cell dysfunction. J Clin Invest 100: 2153-2157
14. Pfeilschifter J, Kunz D, Mühl H (1993) Nitric oxide: an inflammatory mediator of glomerular mesangial cells. Nephron 64: 518-525
15. Furusu A, Miyazaki M, Abe K, et al (1998) Expression of endothelial and inducible nitric oxide synthase in human glomerulonephritis. Kidney Int 53: 1760-1768
16. Zamora R, Vodovotz Y, Billiar TR (2000) Inducible nitric oxide synthase and inflammatory disease. Mol Med 6: 347-373
17. Nitsch DD, Ghilardi N, Mühl H, et al (1997) Apoptosis and expression of inducible nitric oxide synthase are mutually exclusive in renal mesangial cells. Am J Pathol 150: 889-900
18. Marcussen N (1992) Atubular glomeruli and the structural basis for chronic renal failure. Lab Invest 66: 265-284
19. Ardaillou R (1999) Angiotensin II receptors. J Am Soc Nephrol 10: S30-S39
20. 2) angiotensin receptor mediates renal production of nitric oxide in conscious rats. J Clin Invest 100: 264-269
21. Chertin B, Rolle U, Cascio S, et al (2002) Up-regulation of angiotensin II receptors in reflux nephropathy. J Pediatr Surg 37: 251-255